skip to main content

News and Events

Recent Releases

12/13/2017 - 11:45am

Women in Medicine Say #MeToo

After defining the scope of sexual harassment in medicine, a physician says sharing stories and a national reckoning offer hope for progress.
12/07/2017 - 12:00pm

Naive T-cells May Impact Cancer Immunity and Immunotherapy

Most cancer immunotherapy research has targeted effector T cells, but a new study steps back and considers: What if the problem isn’t with the effector T cells, but starts higher up the cellular chain? And so researchers looked at naive T cells -- a type of immune cell that hasn’t yet been triggered to fight.
12/07/2017 - 9:45am

How studying normal cells offers insights into how cancer spreads

Healthy cells migrate only under special circumstances, such as in the early development of an embryo or when new skin cells and blood vessels move in to repair a wound. For a cancer cell to gain access to the body’s major highways -- the blood vessels and lymphatic system -- it has to invade through something.
11/21/2017 - 3:00pm

The Future of Breast Cancer Research

University of Michigan Comprehensive Cancer Center breast cancer researchers discuss the amazing progress of breast cancer research over the past decades and look ahead to the day when it's understood exactly how and why breast cancer spreads so it can be stopped.
11/15/2017 - 12:15pm

Treg Cell Activity May Limit Immunotherapy

Regulatory T cells, or Treg cells, work within the immune system to suppress immune function. Cancer immunotherapy treatments work by supercharging the immune system to fight cancer. So when Tregs come in and suppress the immune response, it shuts down the cancer-fighting effect. But eliminating the Tregs doesn’t help. Researchers have tried, but a clinical trial testing that idea showed no benefit to patients.

All Releases